News for Akebia Therapeutics Stock (AKBA)

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Akebia Investors of a Lead Plaintiff Deadline of May 13, 2022

PRNewsWire • 05/09/22

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 05/04/22

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akebia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AKBA

PRNewsWire • 05/03/22

Akebia Therapeutics (AKBA) Expected to Beat Earnings Estimates: Should You Buy?

Zacks Investment Research • 05/02/22

ROSEN, Global Investor Counsel, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBA

Newsfile Corp • 05/02/22

Akebia Therapeutics to Report First Quarter Financial Results

PRNewsWire • 05/02/22

ROSEN, A TOP RANKED LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 05/01/22

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBA

PRNewsWire • 04/29/22

AKBA INVESTOR NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/25/22

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/23/22

ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important May 13 Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/21/22

AKBA INVESTOR NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 04/20/22

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Akebia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/19/22

ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/17/22

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/16/22

ROSEN, A LEADING AND RANKED FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/14/22

Best Penny Stocks To Buy Now? 5 Stocks Under $1 To Watch In April

PennyStocks • 04/14/22

AKBA INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 04/13/22

AKBA LOSS ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/11/22

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/10/22

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/07/22

Akebia Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2022 to Discuss Your Rights - AKBA

Newsfile Corp • 04/06/22

ROSEN, A LEADING LAW FIRM, Encourages Akebia Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

PRNewsWire • 04/06/22

Akebia Therapeutics Announces Poster Presentations at National Kidney Foundation Spring Clinical Meetings 2022

PRNewsWire • 04/06/22

AKBA INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Akebia Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AKBA

Newsfile Corp • 04/05/22